Severe eosinophilic asthma is a rare type of asthma, that do not respond t the usually asthma drug treatments (corticosteroids). That means that it’s harder to manage, so asthma attacks will possibly occur. This type of asthma involves the abnormal production of type 2 cytokines from T-helper 2 and innate lymphoid cells.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
|---|---|---|---|---|---|---|---|---|---|---|
IL-5 receptor alpha |
Monoclonal Antibody |
Fasenra ® |
30 mg/mL |
– |
1,5 mg |
tba |
tba |
939,00 € |
||
IL-13 , IL-4 |
Monoclonal Antibody |
Dupixent® |
150 mg/mL |
– |
12 mg |
2-8°C/-80°C |
10/2023 |
451,00 € |
||
IL-5 |
Monoclonal Antibody |
Nucala® |
100 mg/mL |
– |
4 mg |
tba |
tba |
529,00 € |
Let us know about your inquiry details and we’ll contact you shortly.
